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Abstract
Background
The aim of  this study was to describe the pattern, outcomes, and determinants of  perioperative complications of  abdominal myomectomy at the 
University of  Ilorin Teaching Hospital, Ilorin, Nigeria.
Methods
This was a retrospective review of  cases of  abdominal myomectomy between January 2010 and December 2013. Data were obtained from ward 
and operating theatre case records and analysed using SPSS version 20. The continuous variables were analysed with Student’s t-test. The categorical 
variables were analysed with the chi-square test. P-values of  0.05 or less was taken to be significant.
Results
Total sampling yielded 204 cases, of  which 170 records (80%) were adequate for analysis. Using criteria developed by Garry et al., major and minor 
complications occurred in 43.6% and 32.9% of  procedures, respectively, while 23.5% of  the patients had no complications. The commonest complication 
was intraoperative haemorrhage requiring blood transfusion. Mean estimated blood loss was 630.88 ± 392.42 mL. There were no cases converted to 
hysterectomy, and no deaths were recorded. Uterine size equivalent to 16 weeks’ gestation or more was significantly associated with heavier blood loss, 
blood transfusion, and fever (P = 0.034). Other significant determinants of  major  intraoperative haemorrhage with or without blood transfusion were 
menstrual flow of  6 days or more, preoperative anaemia, previous surgery, posterior incision, and surgery duration longer than 4 hours (P < 0.05).
Conclusions
Outcome of  abdominal myomectomy is generally favourable even if  uterine size is greater than 16 weeks by palpation. Nevertheless, patients should be 
counselled preoperatively on the risk of  blood loss and the possibility of  blood transfusion.
Introduction
Uterine fibroids (leiomyomas) are the most common benign 
tumours of  the uterus in women of  childbearing age.1 They 
occur in 20% to 25% of  women over the age of  30 years.2 
Abdominal myomectomy is the surgical removal of  fibroid 
tissue through the abdominal route and is often performed 
for women who wish to retain their fertility or reproductive 
function.3 The incidence of  abdominal myomectomy in 
southwestern Nigeria has been reported as 54.7%,2 while a 
rate of  3.34% has been reported for Maiduguri, northeastern 
Nigeria.4 Abdominal myomectomy is the commonest method 
of  treating uterine fibroids and accounts for 60.4% of  cases 
in Ilorin5 and for 90% of  cases in southeastern of  Nigeria.6
Infertility secondary to uterine fibroid is one of  the 
indications for myomectomy7; other indications include 
symptoms such as menorrhagia, recurrent pregnancy loss, 
dysmenorrhoea, lower abdominal swelling, and urinary 
frequency.8,9 Increasingly more women are requiring 
myomectomy as part of  infertility management and, partially 
because of  delayed childbearing, increasingly larger uterine 
myomas are seen in women who desire future fertility 
irrespective of  their age or the number, size, and location 
of  myomas.13 This increases the potential for complications, 
which can be intraoperative or postoperative. Intraoperative 
complications include intraoperative haemorrhage, injury 
to adjacent organs (such as bowel, ureter, and urinary 
bladder), and anaesthetic complications.10 Intraoperative 
blood loss is variable, depending on the size and location 
of  the uterine fibroids.11 Unfortunately for women who 
undergo the procedure because of  their desire to bear 
children, hysterectomy for uncontrollable haemorrhage is a 
known outcome of  intended myomectomy.11 Postoperative 
complications include pyrexia, wound haematoma, and 
infection.10,12
Since myomectomy is a common surgical procedure in 
our setting, delineating the pattern and determinants of  
perioperative complications is important. Studies have shown 
that myomectomy is a safe alternative to hysterectomy for 
women who wish to preserve their reproductive function, 
with no significant difference in perioperative morbidity.14-16 
It is therefore imperative to assess the safety of  this 
uterus-conserving procedure and identify risk factors for 
surgical morbidity in order to ensure adequate preoperative 
preparation and reduce the overall morbidity associated with 
the procedure. The general complications of  myomectomy 
have been enumerated by several authors1-8; the possibilities 
of  predicting them in relation to presenting symptoms, signs, 
and ultrasonographic findings may guide gynaecologists in 
offering preoperative evaluation and counselling. Therefore, a 
retrospective review of  documented findings was undertaken 
to possibly help guide gynaecologists in this respect. This 
study was designed to determine the pattern of  perioperative 
complications of  myomectomy and determinants of  safety 
and outcomes at the University of  Ilorin Teaching Hospital 
(UITH).
Methods
This was a descriptive, retrospective review of  complications 
of  abdominal myomectomy, carried out in the Department 
of  Obstetrics and Gynaecology at UITH, Ilorin, Kwara 
State, Nigeria. The department runs 4 gynaecological clinics 
weekly under the supervision of  consultant staff. Cases 
for surgery are admitted into the gynaecological ward for 
preoperative and anaesthetic reviews a few days before 
scheduled operation days. Operations are carried out in 
the gynaecological suites in the main operating theatre 
and transferred thereafter to the gynaecological ward for 
postoperative care. Patients are booked for clinic follow-up 
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Where, 
N = minimum number of  subjects that need to be enrolled 
in the study to have a statistical power of  80%
p0 = proportion of  sample with postoperative complications 
from a similar study,4 10.9%
p1 = proportion of  sample with postoperative complications 
from this study group, 76.5%
q0 = 1 − p0
q1 = 1 − p1
α  = probability of  type I error, 0.05
β = probability of  type II error, 0.02
z = critical value for a given α or β.
Setting power at 80% (the minimum power), N = 128.
This study used 170 patient records, exceeding the the 
minimum number required for 80% power.
Data were analysed using SPSS software, version 20 
(IBM). The relationships between complications, clinical 
presentations, packed cell volumes, and intraoperative events 
and findings were determined using Student’s t-test (for 
continuous variables) and the chi-square test (for catergorical 
variables). P-values of  0.05 or less were taken to be significant. 
Institutional ethical approval was obtained from the UITH 
Ethical Research Committee before the commencement 
of  the study. Confidentiality of  patient information was 
maintained throught the conduct of  this study.
Results
Total enumeration of  all records of  abdominal myomectomy 
during the period yielded 204 cases; 170 records were 
adequate for analysis, giving a retrieval rate of  80%. The 
sociodemographic characteristics of  the patients are shown 
in Table 1. The mean age of  the population was 34.3 ± 5.6 
years. The majority (70.1%) had tertiary education and 77.1% 
were nulliparous. The case records included in the analysis 
were those of  myomectomies performed by 12 different 
consultant gynaecologists.
Figure 1 shows the clinical presentations of  the patients. 
Most patients had at least 2 presenting complaints—
the commonest was abdominal swelling, followed by 
menorrhagia and infertility. On examination, uterine size was 
greater than the equivalent of  16 weeks’ gestation in about 
half  (52.9%) of  the patients; 35.9% had 12- to 16-week-sized 
uteruses; others were less than 12 weeks.
Frequencies of  major and minor complications17 during and 
after surgery are shown in Table 2. There were complications 
in 76.5% of  all patients who underwent myomectomy; 43.6% 
of  all procedures brought about major complications, while 
32.9% produced minor complications. The commonest 
complication was primary haemorrhage in 45.3% of  
procedures; mean blood loss was 630.9 ± 392.4 mL. The 
estimated blood loss was less than 500 mL in 28.8% of  
cases; 44.1% had blood loss between 500 mL  and 1000 mL, 
while blood loss was greater than 1000 mL in 27.1% of  all 
myomectomies. Ninety-nine patients (58.2%) required blood 
transfusion; 3.5% received at least 5 units of  blood, 42.9% 
received 2 to 4 units, while 20 patients (20.2%) received 
1 unit. Only 1 patient had an anaesthetic complication 
(anaesthesia-related hypotension). The fallopian tubes were 
the most commonly injured organs.
Duration of  admission ranged between 7 and 14 days. Two 
patients were readmitted within 14 days of  discharge: 1 on 
2 weeks after surgery and then monthly for 3 months. If  
there are complications or complaints, consultant review 
may be warranted outside of  these scheduled appointments. 
Patient follow-up for the case notes reviewed in this study 
was limited to 4 weeks.
Case notes of  gynaecological patients who had abdominal 
myomectomy at UITH between January 2010 and December 
2013 were reviewed retrospectively. The information was 
obtained from case folders, anaesthetist operation charts, 
and gynaecological ward and operating theatre records. 
Other gynaecological operations during the period under 
review were excluded.
The sociodemographic characteristics of  the patients, co-
morbidities, previous surgeries and past obstetric history, 
indications for myomectomy, uterine size, and fibroid 
locations were retrieved from case folders.
Preoperative assessments and investigations were noted, 
and pertinent intraoperative data included estimated blood 
loss during surgery, as well as information on anaesthetic 
complications, injury to adjacent organs (such as bowel, 
ureter, or urinary bladder), and duration of  surgery. Study 
staff  also recorded if  conversion to hysterectomy (because 
of  uncontrolled haemorrhage) occurred, and if  (and how 
much) blood was required for transfusion, among other 
findings. Postoperative complications were also noted, 
including any postoperative haemorrhage, anaemia, fever 
(temperature ≥ 38°C, occurring within 24 hours of  surgery), 
wound infection, wound haematoma, duration of  hospital 
stay, postoperative pain, reoperation within 5 days of  
surgery, and readmission after discharge from the hospital 
within 14 days. The complications were divided into minor 
and major according to the criteria described by Garry et 
al.17 Preoperative and postoperative PCV and the differences 
between these figures were also recorded for each patient 
included in the study.
Blood loss estimates from the operative notes reviewed for 
this study were calculated by summing estimates of  blood 
collected intraoperatively via suction, abdominal packs, and 
absorbent gauze. A fully soaked standard abdominal pack is 
estimated to absorb 150 mL of  blood, while the standard 
gauze sheets used at UITH are estimated to absorb 15 mL. 
For procedures carried out in the department, the allowable 
blood loss (ABL) for each patient is calculated using the 
formula:
ABL =
 Total blood volume × (expected PCV − threshold PCV)
preoperative PCV
Patients are transfused intraoperatively when this limit is 
reached. Transfusion may also be commenced if  there is 
undesirable blood loss with features of  hypovolaemic shock. 
Postoperatively, blood is transfused if  there is symptomatic 
anaemia or hypovolaemic shock.
This was a retrospective review and post hoc analysis 
of  statistical power using the observed proportion of  
complications in the study, compared to a past report of  
10.9%,4 determined a power greater than 80%, as calculated 
using the following formula for post hoc analysis of  a 
retrospective study18:
N =
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Table 1: Sociodemographic characteristics
Variable Frequency 
(N = 170) 
Percent
Age group (years)
   ≤ 25  4 2.4
26 – 30 52 30.6
31 – 35 52 30.6
36 – 40 41 24.1
41 – 45 16 9.4
   ≥ 46 5 2.9





















able 1: Sociodemographic characteristics
account of  abdominal pain and vaginal bleeding, while the 
other was on account of  postoperative pyrexia. In this series, 
no cases were converted to hysterectomy and no deaths 
occurred.
Correlates and determinants of complications of 
myomectomy
The duration of  menstrual flow was significantly associated 
with requirement for blood transfusion during and after 
myomectomy (P < 0.001); 99 patients were transfused and 
20 (20.2%) of  them had menstrual flow of  6 days or more. 
The presence of  abdominal swelling with an estimated size 
of  16 weeks’ gestation or more was also significantly related 
Table 1: Sociodemographic characteristics 
(continued)
Variable Frequency 























Table 1: Sociodemographic characteristics (continued)
Figure 1: Presenting complaints of patients who underwent 
myomectomy
Note: some patients had multiple complaints
to the occurrence of  myomectomy-related complications 
(P = 0.013, odds ratio [OR] = 3.83, 95% confidence interval 
[CI] = 1.15 to 13.45). There was no statistically significant 
association between the presence of  either dysmenorrhoea 
or infertility and myomectomy complications (P > 0.05).
Table 3 shows that a uterine size greater than 16 weeks was 
significantly associated with blood loss of  500 mL or more 
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(P < 0.003) and major intraoperative blood loss necessitating 
transfusion (P = 0.017). Febrile morbidity was higher as 
uterine size increased, and this was statistically significant (P 
= 0.034).
Complications were analysed according to preoperative PCV, 
as shown in Table 4. Among the 143 patients who had a PCV 
of  30% or more before surgery, 19.6% had a blood loss of  
500 mL or more; the majority of  patients had less blood loss 
than this.
Haemostatic techniques used were tourniquet at the uterine 
isthmus (94.7%), intramyometrial vasopressin (1.8%), and 
both (3.5%). In terms of  blood loss, none of  the haemostatic 
techniques provided significantly better outcomes than the 
others. No comparison was done between use and non-
use of  haemostatic methods, because at least 1 haemostatic 
technique was used in all procedures included in this series.
Anterior and posterior incisions were used in 55.9% and 
15.3% of  procedures, respectively, while anteroposterior 
incisions were employed in 28.8% of  cases. The use of  
posterior uterine incision was significantly associated with 
increased blood loss (P = 0.045), while anterior incisions had 
the least blood loss (see Table 5).
Using multivariate analysis, a uterine size of  greater than 16 
weeks was a significant predictor of  major intraoperative 
bleeding (P = 0.033, OR = 4.14, 95% CI = 1.12 to 15.27). 
Uterine size (P = 0.035, OR = 3.68. 95% CI = 1.10 to 12.36) 
and previous gynaecological surgery (P = 0.008, OR = 8.049, 
95% CI = 1.72 to 37.66) were also statistically significant 
predictors of  blood transfusion post-myomectomy. The 
previous surgeries documented were myomectomies and 
exploratory laparotomies for ectopic gestations and ovarian 
cysts. There was also a significant association between 
intraoperative haemorrhage (greater than 500 mL of  
blood loss) and duration of  surgery (longer than 4 hours) 
(P = 0.004, OR = 1.95, 95% CI = 1.31 to 2.93). Using a 
Table 2: Major and minor complications after myomectomy using Garry’s Criteria17
Complications
Frequency 
(N = 170) Percent
Major complications
Major intraoperative bleeding requiring blood transfusion 36 21.2
Post operative bleeding requiring blood transfusion 12 7.1
Pelvic or wound haematoma requiring drainage or blood transfusion 1 0.6
Injury to bladder, bowel, ureter, adnexae 16 9.4
Conversion to hysterectomy 0 0.0
Pulmonary embolism 0 0.0
Return to theatre within 3 to 5 days 1 0.6
Wound dehiscence 3 1.8
Readmission within 14 days of surgery 5 2.9
Minor complications
Haemorrhage < 500 mL not requiring blood transfusion 41 24.1
Haematoma not requiring drainage 3 1.8
Deep venous thromboembolism 0 0.0
Wound infection 5 2.9
Fever ≥ 38°C 7 4.1
Table 2: Major and minor complications after myomectomy 
using G rry’s criteria17
! 	1
Table 3: Comparison of uterine size and perioperative complications
Variable





12 to 14 
n (%)





< 500 mL 10 (52.6) 15 (45.5) 7 (25.0) 17 (18.9) 21.92 < 0.001*
500 mL to 1000 mL 5 (26.3) 10 (30.3) 10 (35.7) 50 (55.6) 13.71 < 0.003*
> 1000 mL 4 (21.1) 8 (24.2) 11 (39.3) 23 (25.6) 7.07 0.069
Major intraoperative 
bleed 
Yes 3 (15.8) 3 (9.1) 5 (17.9) 25 (27.8) 10.18 0.017*
No 16 (84.2) 30 (90.9) 23 (82.1) 65 (72.2) 2.18 0.535
Haemorrhage 
< 500 mL
Yes 2 (10.5) 7 (21.2) 4 (14.3) 28 (31.1) 12.73 0.005*
No 17 (89.5) 26 (78.8) 24 (85.7) 62 (68.9) 3.04 0.385
Requirement for 
blood transfusion
Yes 6 (31.6) 13 (39.4) 21(75.0) 59 (65.6) 24.30 < 0.001*
No 13 (68.4) 20 (60.6) 7 (25.0) 31 (34.4) 27.30 < 0.001*
Fever
Yes 0 (0.0) 1 (3.0) 3 (10.7) 3 (3.3) 6.71 0.034*
No 19 (100.0) 32 (97.0) 25 (89.3) 87 (96.7) 0.65 < 0.885
χ2 = chi-square statistic; * = statistically significant
Table 3: Comparison of uterine size and perioperative 
complications
Table 4: Relationship between preoperative packed cell volume (PCV) and 
complications
Variable
Preoperative PCV (N = 170)




Estimated blood loss 
< 500 mL 5 (18.5) 44 (30.8) 3.069 0.079
500 mL to 1000 mL 15 (55.6) 69 (42.0) 1.895 0.168
> 1000 mL 7 (25.9) 39 (27.3) 0.037 0.847
Major intraoperative bleed 
Yes 4 (14.8) 32 (22.4) 1.553 0.212
No 23 (85.2) 111 (77.6) 0.355 0.551
Haemorrhage < 500 mL
Yes 13 (48.1) 28 (19.6) 11.998 <0.001*
No 14 (51.9) 115 (80.4) 6.139 0.013*
Wound infection
Yes 0 (0.0) 5 (3.5) 0.071Y <0.001
No 27 (100.0) 138 (96.5) 0.062 <0.803
Fever
Yes 1 (3.7) 6 (4.2) 0.032Y 0.858
No 26 (96.3) 137 (95.8) 0.001 0.974
χ2 = chi-square statistic; Y = Yates corrected chi-square; * = statistically significant
able 4: Relationship betwe n preoperative packed cell volume 
(PCV) and complications
Table 5: Relationship between uterine incision and estimated blood loss
Variable
Estimated blood loss (mL)
χ2 P-value< 500 
n (%)





Anterior 29 (59.2) 36 (48.0) 30 (65.2) 2.65 0.27
Posterior 4 (8.2) 16 (21.3) 6 (13.0) 6.20 0.045*









Estimated blood loss 
< 500 mL 29 (30.5) 4 (15.4) 16 (32.7) 6.77 0.033*
500 mL to 1000 mL 36 (37.9) 16 (61.5) 23 (46.9) 5.82 0.054
> 1000 mL 30 (31.6) 6 (23.1) 10 (20.4) 2.73 0.26
χ2 = chi-square statistic; * = statistically significant
Table 5: Relationship between uterine incision location and 
estimated blood loss
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binary logistic regression model, uterine size was found to 
best predict blood loss of  500 mL or more, after excluding 
number and location of  fibroids (B = 0.66, P = 0.003, OR = 
1.93, 95% CI = 1.25 to 2.97).
Discussion
The mean age of  patients included in this study was 34.3 ± 
5.6 years. They were all Nigerians of  different ethnicities.
This is comparable to an American study where the incidence 
of  uterine fibroids was 60% at 35 years among African-
American women.19 Fibroids are commoner among women 
of  African descent than among Caucasians and Asians. This 
suggests a probable role of  genetics in the aetiopathogenesis 
of  uterine leiomyomas.
There is evidence of  an inverse relationship between the 
incidence of  fibroids and parity. Pregnancy is known to be 
protective against fibroids; ischaemia of  the uterus during 
parturition and selective apoptosis of  small lesions during 
postpartum uterine remodelling are possible explanations.20-22
In this study, the commonest presenting complaint and 
indication for myomectomy was abdominal swelling, 
followed by menorrhagia and infertility. This is comparable 
with findings from Maiduguri, Nigeria4 but differs from 
results of  other studies in which menorrhagia was found to be 
the commonest presenting complaint.4,14,21,22 The difference 
may be that this review had a more selective study sample, 
while others were epidemiologic descriptive studies of  larger 
sample size. All the same, the presence of  a large fibroid 
seems to be a more common reason to require surgery in 
our environment.
Fibroids caused uterine sizes of  greater than 16 weeks’ 
gestation in half  of  the clients included in this study, and 
this was a major predictor of  intraoperative haemorrhage 
and blood transfusion. Ngichabe et al., in a randomised trial 
similarly reported on the correlation between myoma volume 
and blood loss at open myomectomy.23 In our series, 74.8% 
of  the patients had complications at myomectomy, based 
on Garry’s criteria.17 Primary intraoperative haemorrhage 
was the leading complication and 58.2% of  the patients 
required blood transfusion. Pundir et al., in an analysis of  
200 abdominal myomectomies, found that uterine size of  
20 weeks or more was a major predictor of  perioperative 
bleeding requiring blood transfusion.24 Similarly, West and his 
colleagues reported that 77 out of  the 91 cases of  abdominal 
myomectomy required blood transfusion for perioperative 
blood loss.25 One feature common to these reports and our 
study is the operation of  large uterine fibroids, defined as 
uterine size of  16 weeks or more. It is imperative to counsel 
patients on the possibility of  blood transfusion whenever 
myomectomy is performed. 
In terms of  blood loss, there was no significant differences 
between the intraoperative haemostatic techniques 
(tourniquet and myometrial injection of  vasopressin) used 
in the procedures analysed. The most practiced haemostatic 
method during myomectomy in our centre was the tying 
of  tourniquet around the cervico–isthmic junction of  the 
uterus. This is usually done for 30 to 45 minutes to prevent 
unwanted ischaemic injury and release of  toxic metabolites. 
Vasopressin was used alone for 3 patients and in combination 
with tourniquet in another 6 patients. There was no patient 
for whom at least 1 haemostatic technique was not used. 
Prospective studies on the role of  haemostatic techniques in 
abdominal myomectomies are needed. Use of  preoperative 
medical agents, such as gonadotropin-releasing hormone 
(GnRH) agonists, to reduce fibroid size, help reduce the 
incidence of  intraoperative haemorrhage, but none of  the 
patients studied received such interventions. Other agents 
that cause shrinkage in fibroid size include mifepristone, 
aromatase inhibitors, and ulipristal26-28; these medications are 
not without side effects.
These results show that, even though myomectomy is feasible 
and relatively safe, with large fibroids there is increased risk 
of  heavy blood loss and blood transfusion. This may have 
contributed to the substantial febrile morbidity observed 
in this study, as fever is a common blood transfusion 
reaction. Another cause of  post-myomectomy pyrexia is 
haematoma formation; it may follow improper obliteration 
of  cavities after enucleation of  fibroids. Earlier reports also 
highlighted the risk of  febrile morbidity after myomectomy, 
as demonstrated in this study.16,24,25
Of  the patients who lost less than 500 mL of  blood, 80.4% 
of  them had a preoperative PCV of  at least 30% (P = 
0.013). Adequate PCV may suggest better oxygenation of  
myometrial cells and therefore appropriate circulatory and 
metabolic responses to surgical trauma. It may also be that a 
high concentration of  red cells may indirectly reflect a high 
concentration of  other blood cells, including leucocytes and 
platelets. Although this study did not review the role of  white 
cell count and platelet count in myomectomy outcomes, 
platelets, of  course, contribute to the efficiency of  blood 
coagulation and help reduce excessive blood loss. Effects of  
other haematological parameters on intraoperative blood loss 
during myomectomy could not be determined in this study. 
This limitation highlights the need for future research into 
the roles of  blood parameters in evaluating myomectomy 
outcomes. Other contributing factors to haemorrhage in this 
study were use of  posterior uterine incision and previous 
gynaecological surgeries.
Duration of  surgery longer than 4 hours was significantly 
related to occurrence of  complications (P = 0.004). This 
was contrary to a report by Geidam et al., from Maiduguri,4 
where duration of  surgery was not a significant factor in the 
development of  complications. This is probably because 
the authors also reported that most of  the procedures in 
the Maiduguri study lasted between 60 and 120 minutes. 
Other investigators have demonstrated an independent 
correlation between increased operative time and increased 
perioperative morbidity during abdominal myomectomy; 
the likelihood of  blood transfusion, pulmonary embolism, 
and other complications is increased by increased operative 
time.29 These were more common among patients with 
operation time greater than 3 hours. Presence of  multiple 
fibroids, size of  fibroids, and the need to secure haemostasis 
are common reasons for prolonged operation time during 
abdominal myomectomy. 
For counselling, uterine size less than 16 weeks is associated 
with fewer complications, as is a preoperative PCV of  30% 
or more. Avoidance of  posterior incisions and use of  a 
tourniquet are recommended.30
This was a retrospective review of  170 cases of  abdominal 
myomectomy. Patient follow-up was limited to 2 to 4 weeks 
after surgery, making it difficult to determine outcome after 
this duration.
The myomectomies included in this study were performed 
by various surgeons with differing expertise and experience 
levels. Such variations affect duration of  surgery and other 
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intraoperative events. With that said, a retrospective review 
of  this kind is likely to remove assumptions and biases that 
can occur in prospective designs. However, it is important 
to consider prospective randomised designs with explicit 
criteria, so as to eliminate confounders; for example, this 
review did not distinguish between abdominal myomectomies 
performed as either emergencies or elective cases.
Estimation of  blood loss during surgery is a better 
assessment of  haemorrhage than difference in PCV 
before and after operation. As per departmental protocol, 
surgeons employed tourniquet application as a haemostatic 
method, while vasopressin was added infrequently to further 
reduce haemorrhage, which affected the true blood loss at 
surgery.  In addition, regional anaesthetic techniques, such as 
subarachnoid block, are associated with hypotensive effects 
that impact significantly on blood loss at surgery. Variations 
in anaesthetic technique, as well as the experience and 
expertise of  the surgeons in this study, should be considered 
when interpreting the results of  this study.
Conclusions
Intraoperative haemorrhage necessitating blood transfusion 
is the most common and significant complication that can 
follow abdominal myomectomy. Uterine size, anaemia, 
prolonged surgery time, and posterior uterine incision are 
significant determinants of  complications. Determinants 
of  reduced blood loss and decreased likelihood of  blood 
transfusion include uterine size less than 16 weeks’ gestation, 
absence of  preoperative anaemia, and avoidance of  posterior 
uterine incision where possible.
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